Uscom Stock

Uscom EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Uscom (UCM.AX) as of Jul 15, 2026 is -0.94. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -1.34 — a change of -29.88% (higher).

EV/EBIT

-0.94

YoY

-29.88%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Uscom is 2026 -0.94 . EV/EBIT (Enterprise Value to EBIT) of Uscom was 2025 -1.34 . It decreases by -29.88% higher compared to the previous year.

The Uscom EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
-9.23 base
Jan 1, 2019
-11.53 base
Jan 1, 2020
-18.16 base
Jan 1, 2021
-13.09 base
Jan 1, 2022
-3.10 base
Jan 1, 2023
-2.48 base
Jan 1, 2024
-2.42 base
Jan 1, 2025
-0.66 base
YEARPRICE-TO-EBIT
2025 -0.66
2024 -2.42
2023 -2.48
2022 -3.10
2021 -13.09
2020 -18.16
2019 -11.53
2018 -9.23
2017 -13.24
2016 -12.34
2015 -10.88
2014 -9.07
2013 -4.79
2012 -4.82
2011 -1.07
2010 -6.20
2009 -17.45
2008 -6.96
2007 -3.00
2006 -9.82
Access this data via the Eulerpool API

Uscom Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Uscom's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Uscom's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Uscom's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Uscom grows earnings faster than its peers.

Uscom Stock analysis

What does Uscom do? Uscom Ltd is an Australian company that was founded in 2000. The company focuses on the development, manufacturing, and marketing of medical equipment and devices, with a focus on cardiovascular diagnostics. The company is headquartered in Sydney, Australia, and has branches in Europe, North America, and Asia. Uscom consists of a team of experienced scientists, engineers, and medical professionals who collaborate to manufacture and offer high-quality products that are recognized in the medical field worldwide. Uscom's business model is to develop innovative devices that help doctors and medical professionals diagnose and treat their patients more effectively. Over the years, the company has diversified its portfolio and now offers a variety of products that can be classified into different categories. One of Uscom's main divisions is the manufacturing of ultrasound devices that can be used to measure blood flow, blood pressure, and other important cardiovascular parameters. These devices are particularly useful in the diagnosis and monitoring of patients with cardiovascular diseases such as hypertension, heart failure, and stroke. Uscom also offers a range of devices specifically designed for use in intensive care units and emergency rooms. These devices include non-invasive blood pressure monitors, ventilators, and monitoring systems that enable quick and accurate patient monitoring. These devices are used by medical professionals worldwide to save lives and improve the treatment of critical illnesses. In addition to medical devices, Uscom also provides a variety of training and continuing education programs for medical professionals. These trainings include courses on device usage as well as general trainings on cardiovascular health and diagnosis. In recent years, Uscom has specialized in the development and marketing of telemedicine solutions. These solutions allow doctors and patients to communicate and exchange information remotely. This is particularly useful in providing care to patients in remote areas and in other situations where access to medical professionals is limited. One of Uscom's latest developments is a portable ultrasound Doppler device that can be used to measure blood flow, stroke volume, and other important cardiovascular parameters. This device is lightweight and easy to use, enabling doctors to diagnose patients quickly and accurately in any clinical setting. Overall, Uscom has established a good reputation in the medical industry and is considered a leading company in cardiovascular diagnostics. The company continues its efforts to develop innovative products and solutions that can improve the lives of patients worldwide. Uscom is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uscom stock

EV/EBIT (Enterprise Value to EBIT) of Uscom is -0.94 in 2026.

Access this data via the Eulerpool API

Valuation — Uscom

All Key Metrics — Uscom